OBJECTIVE: Visceral white adipose tissue (WAT) expansion and macrophage accumulation are associated with metabolic dysfunction. Visceral WAT typically shows greater macrophage infiltration. Preadipocytes show varying proinflammatory expression profiles among WAT depots. The objective was to examine the secretomes and chemoattractive properties of preadipocytes from visceral and subcutaneous WAT. METHODS: A label-free quantitative proteomics approach was applied to study secretomes of subcutaneous and omental preadipocytes from obese subjects. Enzyme-linked immunosorbent assays and chemotaxis assays were used to confirm proinflammatory chemokine secretion between depots. RESULTS: Preadipocyte secretomes showed greater variation between depots than did intracellular protein expression. Chemokines were the most differentially secreted proteins. Omental preadipocytes induced chemoattraction of macrophages and monocytes. Neutralizing antibodies to the identified chemokines reduced macrophage/monocyte chemoattraction. Subcutaneous preadipocytes treated with interleukin-6 (IL-6) resembled omental preadipocytes in terms of chemokine secretion and macrophage/monocyte chemoattraction. Janus-activated kinase (JAK1/2) protein expression, which transduces IL-6 signaling, was higher in omental than subcutaneous preadipocytes and WAT. Inhibiting JAK in omental preadipocytes decreased chemokine secretion and macrophage/monocyte chemoattraction to levels closer to that observed in subcutaneous preadipocytes. CONCLUSIONS: Secretomes of omental and subcutaneous preadipocytes are distinct, with the former inducing more macrophage/monocyte chemoattraction, in part through IL-6/JAK-mediated signaling.
OBJECTIVE: Visceral white adipose tissue (WAT) expansion and macrophage accumulation are associated with metabolic dysfunction. Visceral WAT typically shows greater macrophage infiltration. Preadipocytes show varying proinflammatory expression profiles among WAT depots. The objective was to examine the secretomes and chemoattractive properties of preadipocytes from visceral and subcutaneous WAT. METHODS: A label-free quantitative proteomics approach was applied to study secretomes of subcutaneous and omental preadipocytes from obese subjects. Enzyme-linked immunosorbent assays and chemotaxis assays were used to confirm proinflammatory chemokine secretion between depots. RESULTS: Preadipocyte secretomes showed greater variation between depots than did intracellular protein expression. Chemokines were the most differentially secreted proteins. Omental preadipocytes induced chemoattraction of macrophages and monocytes. Neutralizing antibodies to the identified chemokines reduced macrophage/monocyte chemoattraction. Subcutaneous preadipocytes treated with interleukin-6 (IL-6) resembled omental preadipocytes in terms of chemokine secretion and macrophage/monocyte chemoattraction. Janus-activated kinase (JAK1/2) protein expression, which transduces IL-6 signaling, was higher in omental than subcutaneous preadipocytes and WAT. Inhibiting JAK in omental preadipocytes decreased chemokine secretion and macrophage/monocyte chemoattraction to levels closer to that observed in subcutaneous preadipocytes. CONCLUSIONS: Secretomes of omental and subcutaneous preadipocytes are distinct, with the former inducing more macrophage/monocyte chemoattraction, in part through IL-6/JAK-mediated signaling.
Authors: Tamara Tchkonia; Thomas Thomou; Yi Zhu; Iordanes Karagiannides; Charalabos Pothoulakis; Michael D Jensen; James L Kirkland Journal: Cell Metab Date: 2013-04-11 Impact factor: 27.287
Authors: Maarit K Valtonen; David E Laaksonen; Jari A Laukkanen; Tommi Tolmunen; Heimo Viinamäki; Hanna-Maaria Lakka; Timo A Lakka; Leo Niskanen; Jussi Kauhanen Journal: Scand J Public Health Date: 2012-10-05 Impact factor: 3.021
Authors: Bret H Goodpaster; Shanthi Krishnaswami; Helaine Resnick; David E Kelley; Catherine Haggerty; Tamara B Harris; Ann V Schwartz; Steven Kritchevsky; Anne B Newman Journal: Diabetes Care Date: 2003-02 Impact factor: 19.112
Authors: Ilan Gabriely; Xiao Hui Ma; Xiao Man Yang; Gil Atzmon; Michael W Rajala; Anders H Berg; Phillip Scherer; Luciano Rossetti; Nir Barzilai Journal: Diabetes Date: 2002-10 Impact factor: 9.461
Authors: Marta Izabela Jonas; Alina Kurylowicz; Zbigniew Bartoszewicz; Wojciech Lisik; Maurycy Jonas; Zbigniew Wierzbicki; Andrzej Chmura; Piotr Pruszczyk; Monika Puzianowska-Kuznicka Journal: Int J Mol Sci Date: 2015-10-28 Impact factor: 5.923
Authors: Arturo Roca-Rivada; Susana Belen Bravo; Diego Pérez-Sotelo; Jana Alonso; Ana Isabel Castro; Iván Baamonde; Javier Baltar; Felipe F Casanueva; María Pardo Journal: Sci Rep Date: 2015-07-22 Impact factor: 4.379
Authors: Kyoung-Jin Oh; Da Som Lee; Won Kon Kim; Baek Soo Han; Sang Chul Lee; Kwang-Hee Bae Journal: Int J Mol Sci Date: 2016-12-22 Impact factor: 5.923
Authors: Joanna Gertow; Chang Zhi Ng; Rui Miguel Mamede Branca; Olivera Werngren; Lei Du; Sanela Kjellqvist; Peter Hemmingsson; Annette Bruchfeld; Helen MacLaughlin; Per Eriksson; Jonas Axelsson; Rachel M Fisher Journal: Kidney Int Rep Date: 2017-07-29